Showing results (261-270 of 1,013) with videos related to

Sort By:
Pageof 102
Cancer Research Communications|October 12, 2023
Concurrent Targeting of HDAC and PI3K to Overcome Phenotypic Heterogeneity of Castration-resistant and Neuroendocrine Prostate CancersAilin Zhang, Nathan A Lau, Alicia Wong, et al.
Cancer Research Communications|October 26, 2023
Activation of KrasG12D in Subset of Alveolar Type II Cells Enhances Cellular Plasticity in Lung AdenocarcinomaPriyanka Chaudhary, Xia Xu, Guangfang Wang, et al.
Cancer Research Communications|September 29, 2023
Pancreatic Ductal Adenocarcinoma Cells Regulate NLRP3 Activation to Generate a Tolerogenic MicroenvironmentJesus Amo-Aparicio, Adrian Dominguez, Shaikh M Atif, et al.
Cancer Research Communications|October 2, 2023
Change in Neighborhood Socioeconomic Status and Adherence to the Cancer Prevention Lifestyle Guidelines in Hispanic/Latino Adults: Results from the HCHS/SOL StudyMargaret S Pichardo, Catherine M Pichardo, Gregory A Talavera, et al.
Cancer Research Communications|September 29, 2023
Effects and Eradication of Mycoplasma Contamination on Patient-derived Colorectal Cancer Organoid CulturesDivya L Dayanidhi, Wylie K Watlington, John B Mantyh, et al.
Cancer Research Communications|July 19, 2023
Siglec-15 Promotes Evasion of Adaptive Immunity in B-cell Acute Lymphoblastic LeukemiaClaire E Pillsbury, Jodi Dougan, Jennifer L Rabe, et al.
Cancer Research Communications|July 5, 2023
Targeting the Clear Cell Sarcoma Oncogenic Driver Fusion Gene EWSR1::ATF1 by HDAC InhibitionHirokazu Mae, Hidetatsu Outani, Yoshinori Imura, et al.
Cancer Research Communications|July 3, 2023
Multi-institutional Prognostic Modeling in Head and Neck Cancer: Evaluating Impact and Generalizability of Deep Learning and RadiomicsMichal Kazmierski, Mattea Welch, Sejin Kim, et al.
Cancer Research Communications|June 30, 2023
Quantitative DNA Repair Biomarkers and Immune Profiling for Temozolomide and Olaparib in Metastatic Colorectal CancerMichael Cecchini, Janie Y Zhang, Wei Wei, et al.
Cancer Research Communications|July 21, 2023
Metronomic Administration of Topotecan Alone and in Combination with Docetaxel Inhibits Epithelial-mesenchymal Transition in Aggressive Variant Prostate CancersTaraswi Mitra Ghosh, Suman Mazumder, Joshua Davis, et al.
Pageof 102